Google Übersetzer
Karyopharm Therapeutics Inc
About
Karyopharm Therapeutics Inc (NASDAQ:KPTI) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 24 2026
Karyopharm Announces $30 Million Private Placement with RA Capital
Mar 24 2026
Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction
Feb 12 2026
Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
Feb 5 2026
Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
Feb 2 2026
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Financials
Revenue
$146.07 M
Market Cap
$142.47 M
EPS
-17.93